Mohini Health NSE SME IPO Review (Apply)

Review By on January 30, 2018

Mohini Health & Hygiene Ltd. (MHHL) is an ISO 9001(QMS), ISO 14001 (EMS) and 18001 (OHSAS) certified company engaged in manufacturing and export of absorbent cotton and medical consumable products.  It was formerly known as Mohini Fibers Ltd. and was engaged in the business of dealing and processing of cotton and waste cotton and lately diversified into the health and hygiene sector with the change in name. MHHL operates both in domestic and international markets and has been awarded as Star Export House by Office of the Joint Director General of Foreign Trade. It has transferred its cotton waste recycling business activity to its subsidiary Vedant Kotton Pvt. Ltd. Its product portfolio includes Absorbent Bleached Surgical Cotton, Absorbent Cotton Wool, Cotton Balls, Cotton Ear Buds, Cotton Zig Zag etc.

To part finance its repayment/prepayment of debt, working capital and general corpus fund needs, MHHL is coming out with a maiden IPO of 4932000 equity shares of Rs.10 each via book building route in a price band of Rs. 40 – Rs. 42 per share to mobilize Rs. 19.73 cr. to Rs. 20.71 cr. (based on lower and upper price bands). Issue opens for subscription on 05.02.18 and will close on 07.02.18.Minimum application is to be made for 3000 shares and in multiples thereon, thereafter. Post allotment, shares will be listed on NSE SME Emerge. Issue is jointly lead managed by Pantomath Capital Advisors Pvt. Ltd. and Small Industries Development Bank of India (SIDBI). Link Intime India Pvt. Ltd. is the registrar to the issue. Having raised initial equity at par between incorporation and January 2010, it also raised few shares at par in March 2014. It raised further equity in the price range of Rs. 30 to Rs. 80 per share between March 2011 and January 2018. It has also issued bonus shares in the ratio of 3 for 1 in November 2017. Post issue, MHHL’s current paid up equity capital of Rs. 13.30 cr. will stand enhanced to Rs. 18.24 cr. Issue constitutes 27.04% of post issue paid up capital of the company. 

On performance front, MHHL has posted turnover/net profits of Rs. 48.69 cr. / Rs. 0.73 cr. (FY14), Rs. 91.04 cr. / Rs. 1.93 cr. (FY15), Rs. 123.09 cr. / Rs. 3.82 cr. (FY16), Rs. 137.73 cr. / Rs. 3.39 cr. (FY17). Thus while top line maintained growth pattern, it suffered a setback in bottom line for FY17. For first half of the current fiscal, it has earned net profit of Rs. 3.64 cr. on a turnover of Rs. 85.17 cr. which is a bit surprising. For last three fiscals, it has posted an average EPS of Rs. 2.85 and an average RoNW of 16.15% on an equity base of Rs. 2.96 crore that has quantum jump now and will further rise post issue. Issue is priced at a P/BV of 0.44 based on its NAV of Rs.95.09 as on 30.09.17. If we annualize latest earnings and attribute it on fully diluted post issue equity then asking price is at a P/E of around 11 that augurs well. It has no listed peers to compare with.

On merchant banker’s front, this is the 61st mandate from its stable in last three fiscals. Out of last 10 listings, 1 opened around par and the rest with premiums ranging from 1% to 130% on the day of listing. 130% rewards are from the only main board IPO of this merchant banker i.e. Astron Paper


Conclusion / Investment Strategy

Considering reasonable pricing and the future prospects for this company, investment may be considered for short to long term.

Reviewer recommends Subscribing to the issue.

Review By on January 30, 2018

About Dilip Davda

Dilip Davda, SEBI Registered Research Analyst

Dilip Davda is a veteran financial journalist associated with the Indian stock market since 1978. He has been contributing to print and electronic media on capital markets, insurance, and finance since 1985.

He is widely recognized for reviewing public issues and non-convertible debentures (NCDs) in the primary market. Drawing on over three decades of market experience and close interaction with merchant bankers, his reviews focus on detailed fundamental and financial analysis of companies, with a special emphasis on SME public issues.

Dilip Davda

SEBI Registered Research Analyst – Mumbai

Registration No.: INH000003127 (Perpetual)

Email: dilip_davda@rediffmail.com


Disclaimer: The information provided herein is solely for educational and informational purposes and does not constitute an offer, solicitation, or recommendation to buy or sell any securities. Readers are advised to consult a qualified financial advisor before making any investment decisions. Investments in the securities market are subject to market risks. The author does not intend to invest in the securities discussed.

Mohini Health IPO FAQs

The initial public offer (IPO) of Mohini Health & Hygiene Ltd. offers an early investment opportunity in Mohini Health & Hygiene Ltd.. A stock market investor can buy Mohini Health IPO shares by applying in IPO before Mohini Health & Hygiene Ltd. shares get listed at the stock exchanges. An investor could invest in Mohini Health IPO for short term listing gain or a long term.

Read the Mohini Health IPO recommendations by the leading analyst and leading stock brokers.

Mohini Health IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the Mohini Health IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts mentioned in the above answer to "How is Mohini Health IPO?"

Our recommendation for Mohini Health IPO is to subscribe.

As per the analysis by our lead analyst Mr. Dilip Davda, we suggest you to subscribe to the Mohini Health IPO.

The Mohini Health IPO allotment status will be available on or around February 12, 2018. The allotted shares will be credited in demat account by February 15, 2018. Visit Mohini Health IPO allotment status to check.

The Mohini Health IPO will list on Friday, February 16, 2018.

Read more about Mohini Health IPO

Mohini Health NSE SME IPO Review